These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PET studies of cerebral metabolism in Parkinson disease. Powers WJ J Bioenerg Biomembr; 2009 Dec; 41(6):505-8. PubMed ID: 19904589 [TBL] [Abstract][Full Text] [Related]
3. Selective defect of in vivo glycolysis in early Huntington's disease striatum. Powers WJ; Videen TO; Markham J; McGee-Minnich L; Antenor-Dorsey JV; Hershey T; Perlmutter JS Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2945-9. PubMed ID: 17299049 [TBL] [Abstract][Full Text] [Related]
4. Platelet mitochondrial complex I and I+III activities do not correlate with cerebral mitochondrial oxidative metabolism. Powers WJ; Haas RH; Le T; Videen TO; Markham J; Perlmutter JS J Cereb Blood Flow Metab; 2011 Jan; 31(1):e1-5. PubMed ID: 20959851 [TBL] [Abstract][Full Text] [Related]
5. Cerebral oxygen metabolism in patients with early Parkinson's disease. Borghammer P; Cumming P; Østergaard K; Gjedde A; Rodell A; Bailey CJ; Vafaee MS J Neurol Sci; 2012 Feb; 313(1-2):123-8. PubMed ID: 21975016 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson's disease patients uncovers metabolic and mitochondrial bioenergetic defects. Deus CM; Pereira SP; Cunha-Oliveira T; Pereira FB; Raimundo N; Oliveira PJ Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165615. PubMed ID: 31759069 [TBL] [Abstract][Full Text] [Related]
7. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Hattingen E; Magerkurth J; Pilatus U; Mozer A; Seifried C; Steinmetz H; Zanella F; Hilker R Brain; 2009 Dec; 132(Pt 12):3285-97. PubMed ID: 19952056 [TBL] [Abstract][Full Text] [Related]
8. Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson's disease. Milanese C; Payán-Gómez C; Galvani M; Molano González N; Tresini M; Nait Abdellah S; van Roon-Mom WMC; Figini S; Marinus J; van Hilten JJ; Mastroberardino PG Mov Disord; 2019 Aug; 34(8):1192-1202. PubMed ID: 31136028 [TBL] [Abstract][Full Text] [Related]
9. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease. Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255 [TBL] [Abstract][Full Text] [Related]
10. High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's disease. Eggers C; Hilker R; Burghaus L; Schumacher B; Heiss WD J Neurol Sci; 2009 Jan; 276(1-2):27-30. PubMed ID: 18835490 [TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson's disease. Winkler-Stuck K; Kirches E; Mawrin C; Dietzmann K; Lins H; Wallesch CW; Kunz WS; Wiedemann FR J Neural Transm (Vienna); 2005 Apr; 112(4):499-518. PubMed ID: 15340872 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial metabolism modulation: a new therapeutic approach for Parkinson's disease. Arduíno DM; Esteves AR; Oliveira CR; Cardoso SM CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):105-19. PubMed ID: 20201821 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia. Garcia-Esparcia P; Koneti A; Rodríguez-Oroz MC; Gago B; Del Rio JA; Ferrer I Brain Pathol; 2018 Jan; 28(1):43-57. PubMed ID: 27984680 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial biology and Parkinson's disease. Perier C; Vila M Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a009332. PubMed ID: 22355801 [TBL] [Abstract][Full Text] [Related]
15. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Holthoff VA; Vieregge P; Kessler J; Pietrzyk U; Herholz K; Bönner J; Wagner R; Wienhard K; Pawlik G; Heiss WD Ann Neurol; 1994 Aug; 36(2):176-82. PubMed ID: 8053653 [TBL] [Abstract][Full Text] [Related]
17. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease]. Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030 [TBL] [Abstract][Full Text] [Related]
18. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Büeler H Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005 [TBL] [Abstract][Full Text] [Related]
19. Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature. Das B; Dash SP; Mohanty S; Patel P Adv Exp Med Biol; 2021; 1286():65-76. PubMed ID: 33725345 [TBL] [Abstract][Full Text] [Related]
20. Low thalamic monoamine transporter availability is related to excessive daytime sleepiness in early Parkinson's disease. Yoo SW; Oh YS; Ryu DW; Lee KS; Lyoo CH; Kim JS Neurol Sci; 2020 May; 41(5):1081-1087. PubMed ID: 31872354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]